相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypoxia-inducible factor-1α and-2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis
S. Rasheed et al.
BRITISH JOURNAL OF CANCER (2009)
Heterozygosity for Hypoxia Inducible Factor 1α Decreases the Incidence of Thymic Lymphomas in a p53 Mutant Mouse Model
Jessica A. Bertout et al.
CANCER RESEARCH (2009)
Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
Johanna Chiche et al.
CANCER RESEARCH (2009)
HIF-1α and HIF-2α have divergent roles in colon cancer
Takaaki Imamura et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma
Klaus Juergen Schmitz et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
David R. Mole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer
Simona Nanni et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects
David L. Schwartz et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Targeted Systemic Delivery of a Therapeutic siRNA with a Multifunctional Carrier Controls Tumor Proliferation in Mice
Xu-Li Wang et al.
MOLECULAR PHARMACEUTICS (2009)
Targeting Hypoxia-inducible Factor-1α With Tf-PEI-shRNA Complex via Transferrin Receptor-mediated Endocytosis Inhibits Melanoma Growth
Yeqiang Liu et al.
MOLECULAR THERAPY (2009)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
被撤回的出版物: Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells (Retracted article. See vol. 119, 2022)
KangAe Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Gregg L. Semenza
SEMINARS IN CANCER BIOLOGY (2009)
Hypoxia-specific stabilization of HIF-1 alpha by human papillomaviruses
Mitsuhiro Nakamura et al.
VIROLOGY (2009)
Comment on the role of FIH in the inhibitory effect of bortezomib on hypoxia-inducible factor-1
Stefan Kaluz et al.
BLOOD (2008)
Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1
Dong Hoon Shin et al.
BLOOD (2008)
Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study
Alexandros Daponte et al.
BMC CANCER (2008)
Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1α to induce vascular endothelial growth factor expression
Young C. Shin et al.
CANCER RESEARCH (2008)
Expression of hypoxia-inducible factor (HIF)-1 alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma
Ching Tzao et al.
DISEASE MARKERS (2008)
The role of hypoxia in recurrence following resection of Dukes' B colorectal cancer
R. Rajaganeshan et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Overexpression of intrinsic hypoxia markers HIF1α and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy
M. L. Schrijivers et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Huafeng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Mark W. Dewhirst et al.
NATURE REVIEWS CANCER (2008)
Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer
Yutaka Yamamoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Hypoxia and metabolism - Opinion - A microenvironmental model of carcinogenesis
Robert A. Gatenby et al.
NATURE REVIEWS CANCER (2008)
Hypoxia and cancer
M. Christiane Brahimi-Horn et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
A potential α-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1α in normoxia
Qiliang Cai et al.
JOURNAL OF VIROLOGY (2007)
HIF-dependent antitumorigenic effect of antioxidants in vivo
Ping Gao et al.
CANCER CELL (2007)
Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells
Mariko Tomita et al.
BIOCHEMICAL JOURNAL (2007)
Regulation of tumor pH and the role of carbonic anhydrase 9
Pawel Swietach et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia-driven selection of the metastatic phenotype
Richard Sullivan et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Benjamin J. Moeller et al.
CANCER AND METASTASIS REVIEWS (2007)
Metastasis and stem cell pathways
Bryan C. Barnhart et al.
CANCER AND METASTASIS REVIEWS (2007)
Targeting hypoxia cell signaling for cancer therapy
Giovanni Melillo
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues
D. Lukashev et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia: A key regulator of angiogenesis in cancer
Debbie Liao et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia and adaptive landscapes in the evolution of carcinogenesis
Robert J. Gillies et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia, gene expression, and metastasis
Denise A. Chan et al.
CANCER AND METASTASIS REVIEWS (2007)
Regulation of DNA repair in hypoxic cancer cells
Ranjit S. Bindra et al.
CANCER AND METASTASIS REVIEWS (2007)
Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1) -: A negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells
Yuichi Makino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer
Toru Hiraga et al.
CANCER RESEARCH (2007)
Target gene selectivity of hypoxia-inducible factor-α in renal cancer cells is conveyed by post-DNA-binding mechanisms
K. W. Lau et al.
BRITISH JOURNAL OF CANCER (2007)
Regulation of HIF-1α stability through S-nitrosylation
Fang Li et al.
MOLECULAR CELL (2007)
HIF-1α and CA IX staining in invasive breast carcinomas:: Prognosis and treatment outcome
Cynthia Trastour et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α
Ye V. Liu et al.
MOLECULAR CELL (2007)
Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression
Debbie Liao et al.
CANCER RESEARCH (2007)
Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas
E. A. Griffiths et al.
BRITISH JOURNAL OF CANCER (2007)
EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1α through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells
Satoru Kondo et al.
CANCER RESEARCH (2006)
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors
Qi-Liang Cai et al.
PLOS PATHOGENS (2006)
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α
David Z. Qian et al.
CANCER RESEARCH (2006)
Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1α C-terminal activation domain
Stefan Kaluz et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Hypoxia-inducible factor-1α-expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer
Daniele Generali et al.
CLINICAL CANCER RESEARCH (2006)
Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response
Å Kronblad et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-α
DM Fath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effect of antisense hypoxia-inducible factor 1α on progression, metastasis, and chemosensitivity of pancreatic cancer
Qing Chang et al.
PANCREAS (2006)
EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms
N Pore et al.
CANCER RESEARCH (2006)
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B
B Krishnamachary et al.
CANCER RESEARCH (2006)
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α
XG Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1α in cancer:: Role of free radical formation
M Quintero et al.
CANCER RESEARCH (2006)
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
GV Thomas et al.
NATURE MEDICINE (2006)
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
DH Kong et al.
CANCER RESEARCH (2005)
Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1α accumulation and activity by disrupting microtubule function
D Escuin et al.
CANCER RESEARCH (2005)
Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer:: Retrospective study in a series of 745 patients
JP Dales et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Evaluating hypoxia-inducible factor-1α as a cancer therapeutic target via inducible RNA interference in vivo
LM Li et al.
CANCER RESEARCH (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression
RB Luwor et al.
ONCOGENE (2005)
HIF-1α induces genetic instability by transcriptionally downregulating MutSα expression
M Koshiji et al.
MOLECULAR CELL (2005)
Transcriptional regulation of the Vascular Endothelial Growth Factor gene -: a concert of activating factors
G Pagès et al.
CARDIOVASCULAR RESEARCH (2005)
Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer
MM Vleugel et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Evaluation of hypoxia-inducible factor 1α overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma
VE Theodoropoulos et al.
BJU INTERNATIONAL (2005)
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
DJ Manalo et al.
BLOOD (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
U Cavallaro et al.
NATURE REVIEWS CANCER (2004)
Hypoxia-inducible factor-1α in non small cell lung cancer:: Relation to growth factor, protease and apoptosis pathways
DEB Swinson et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Hypoxia-inducible factor 1α expression correlates with angiogenesis and unfavorable prognosis in bladder cancer
VE Theodoropoulos et al.
EUROPEAN UROLOGY (2004)
c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-lot dependent
A Giatromanolaki et al.
CLINICAL CANCER RESEARCH (2004)
The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-α
YG Yoo et al.
FEBS LETTERS (2004)
Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis
N Tang et al.
CANCER CELL (2004)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
Hypoxia-inducible factor 1α/vascular endothelial growth factor axis in astrocytomas.: Associations with microvessel morphometry, proliferation and prognosis
P Korkolopoulou et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2004)
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel et al.
NATURE REVIEWS CANCER (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
Hypoxia-inducible factors 1α and 2α are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin
A Giatromanolaki et al.
MELANOMA RESEARCH (2003)
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
JB Brugarolas et al.
CANCER CELL (2003)
Significant correlation of hypoxia-inducible factor-1α with treatment outcome in cervical cancer treated with radical radiotherapy
P Burri et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Tumor response to radiotherapy regulated by endothelial cell apoptosis
M Garcia-Barros et al.
SCIENCE (2003)
Dominant-negative hypoxia-inducible factor-1α reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism
J Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma
R Bos et al.
CANCER (2003)
Minimizing long-term tumor burden: The logic for metronomic chemotherapeutic dosing and its antiangiogenic basis
P Hahnfeldt et al.
JOURNAL OF THEORETICAL BIOLOGY (2003)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
M Mayerhofer et al.
BLOOD (2002)
Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma
E Sivridis et al.
CANCER (2002)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer
MI Koukourakis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
D Lando et al.
GENES & DEVELOPMENT (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
A Giatromanolaki et al.
BRITISH JOURNAL OF CANCER (2001)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Suppression of tumor growth through disruption of hypoxia-inducible transcription
AL Kung et al.
NATURE MEDICINE (2000)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
